ARS Pharmaceuticals, Inc. Forecasted to Earn FY2024 Earnings of ($0.60) Per Share (NASDAQ:SPRY)

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Stock analysts at Leerink Partnrs decreased their FY2024 EPS estimates for ARS Pharmaceuticals in a report released on Monday, August 12th. Leerink Partnrs analyst R. Ruiz now expects that the company will post earnings per share of ($0.60) for the year, down from their previous forecast of […]

Leave a Reply

Your email address will not be published.

Previous post FY2024 EPS Estimates for Orla Mining Ltd. Decreased by Stifel Canada (TSE:OLA)
Next post FY2025 EPS Estimates for Vitalhub Corp. Decreased by Cormark (TSE:VHI)